Literature DB >> 9779161

Relationship of neuron specific enolase and protein S-100 concentrations in systemic and jugular venous serum to injury severity and outcome after traumatic brain injury.

E G McKeating1, P J Andrews, L Mascia.   

Abstract

Neuron specific enolase (NSE) and protein S-100 have previously been described as markers of brain injury. We aimed to discover whether concentrations of either were raised in arterial and jugular venous serum after traumatic brain injury, and whether serum profiles were related to injury severity and neurological outcome. We recruited 22 patients with a traumatic brain injury who were admitted to the intensive care unit. Paired arterial and jugular venous blood samples were taken on admission, and at 24, 48 and 96 hrs after injury. Samples were analysed for NSE and S-100 by RIA. Concentrations of both NSE and S-100 were increased above controls--mean NSE concentration was highest on admission, whilst mean S-100 peaked at 24 hours after injury. There was a small, but significant difference between jugular venous and arterial concentrations of S-100 (p = 0.022). High NSE and S-100 concentrations were significantly related to poor neurological outcome (p = 0.004 and p < 0.001 respectively). Both serum NSE and S-100 may be of some value in helping to predict outcome after a traumatic brain injury.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9779161     DOI: 10.1007/978-3-7091-6475-4_35

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  15 in total

Review 1.  Blood-based diagnostics of traumatic brain injuries.

Authors:  Stefania Mondello; Uwe Muller; Andreas Jeromin; Jackson Streeter; Ronald L Hayes; Kevin K W Wang
Journal:  Expert Rev Mol Diagn       Date:  2011-01       Impact factor: 5.225

2.  Predictive value of neuron-specific enolase for prognosis in patients with moderate or severe traumatic brain injury: a systematic review and meta-analysis.

Authors:  Eric Mercier; Amélie Boutin; Michèle Shemilt; François Lauzier; Ryan Zarychanski; Dean A Fergusson; Lynne Moore; Lauralyn A McIntyre; Patrick Archambault; France Légaré; François Rousseau; François Lamontagne; Linda Nadeau; Alexis F Turgeon
Journal:  CMAJ Open       Date:  2016-07-22

3.  Serum S-100B protein monitoring in patients with severe traumatic brain injury.

Authors:  Stefanos Korfias; George Stranjalis; Efstathios Boviatsis; Christina Psachoulia; Gerard Jullien; Barbara Gregson; A David Mendelow; Damianos E Sakas
Journal:  Intensive Care Med       Date:  2006-12-02       Impact factor: 17.440

4.  Concentration of neuron-specific enolase and S100 protein in the subretinal fluid of rhegmatogenous retinal detachment.

Authors:  J C Quintyn; F Pereira; M F Hellot; G Brasseur; A Coquerel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-05-20       Impact factor: 3.117

5.  Release of biochemical markers of damage to neuronal and glial brain tissue is associated with short and long term neuropsychological outcome after traumatic brain injury.

Authors:  M Herrmann; N Curio; S Jost; C Grubich; A D Ebert; M L Fork; H Synowitz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-01       Impact factor: 10.154

6.  αII-spectrin breakdown products (SBDPs): diagnosis and outcome in severe traumatic brain injury patients.

Authors:  Stefania Mondello; Steven A Robicsek; Andrea Gabrielli; Gretchen M Brophy; Linda Papa; Joseph Tepas; Claudia Robertson; Andras Buki; Dancia Scharf; Mo Jixiang; Linnet Akinyi; Uwe Muller; Kevin K W Wang; Ronald L Hayes
Journal:  J Neurotrauma       Date:  2010-07       Impact factor: 5.269

7.  Biomarker evidence for mild central nervous system injury after surgically-induced circulation arrest.

Authors:  Robert Siman; Victoria L Roberts; Elizabeth McNeil; Antony Dang; Joseph E Bavaria; Sindhu Ramchandren; Michael McGarvey
Journal:  Brain Res       Date:  2008-04-01       Impact factor: 3.252

8.  Effects of sevoflurane before cardiopulmonary bypass on cerebral oxygen balance and early postoperative cognitive dysfunction.

Authors:  Ji-Hong Xu; Tie-Zheng Zhang; Xiao-Feng Peng; Chun-Ji Jin; Jin Zhou; Yi-Nan Zhang
Journal:  Neurol Sci       Date:  2013-03-23       Impact factor: 3.307

9.  A panel of neuron-enriched proteins as markers for traumatic brain injury in humans.

Authors:  Robert Siman; Nikhil Toraskar; Antony Dang; Elizabeth McNeil; Micheal McGarvey; Justin Plaum; Eileen Maloney; M Sean Grady
Journal:  J Neurotrauma       Date:  2009-11       Impact factor: 5.269

10.  Biomarkers in the clinical diagnosis and management of traumatic brain injury.

Authors:  Georgene W Hergenroeder; John B Redell; Anthony N Moore; Pramod K Dash
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.